Home  ›  UK  ›  Hikma Pharmaceuticals Public Limited Company

Hikma Pharmaceuticals Public Limited Company insider transactions

Healthcare · LSE · UK
Net insider signal · last quarter
Buying
Share price & insider trades · last quarter▲ buy   ▼ sell
£ 1798.4£ 1270.610 Apr09 Jul

Insiders were buyers over the last quarter — 1 purchase, no sells — a net £199K of buying. Most recent filing: 27 Apr 2026.

Net insider flow · last quarter
+£199K1 buys · 0 sells
Insider profiles
＋●.●% avg 3m · win rate
🔒  Subscribe to access

Transactions

DateInsiderRoleTypeValue
27 Apr 2026Victoria HullNon-Executive ChairBuy£198,901
09 Mar 2026Hussein ArkhaghaPDMRBuy£74,400
19 Dec 2025Mazen DarwazahExecutive Vice ChairmanBuy£1,498,600
Discover the latest filings, live alerts, top insiders and industry rankings →
07 Nov 2025Said DarwazahExecutive Chairman▲ Buy£1,605,000
06 Nov 2025Mazen DarwazahExecutive Vice Chairman▲ Buy£1,828,500
22 Sep 2025Riad MishlawiChief Executive Officer▲ Buy£27,384
16 Sep 2025Mazen DarwazahExecutive Vice Chairman▲ Buy£224,420
22 Aug 2025Laura BalanNon-Executive Director▲ Buy£63,724
07 Aug 2025Mazen DarwazahExecutive Vice Chairman▲ Buy£3,512,000
06 Jun 2025Bassam KanaanPDMR▼ Sell£842,000
04 Jun 2025Dr Bill LarkinsPDMR▼ Sell£111,869
Showing older filings · the 3 most recent are subscriber-only
Visit the website →

Under the EU Market Abuse Regulation (MAR), executives and board members (PDMRs) at UK-listed companies must disclose dealings in their company's shares to FCA. Insider Transaction Terminal aggregates these filings daily, filters out the noise and gives you the trades that actually matter.